Your immune system's master trainer—a naturally occurring thymus peptide that wakes up tired immune cells, helps your body fight infections, and keeps your defenses sharp as you age.
Written by Michael Carroll — Owner, Director of Research · Reviewed by the Peptide Initiative Research Team · Editorial standards
Subcutaneous
Route
3 recommended
Sites
Twice weekly
Frequency
Preparation
Bacteriostatic water (BAC water)—the preservative keeps it safe for multiple doses
Insulin syringes (29-31 gauge) for precise dosing
Alcohol swabs for cleaning vial tops and injection sites
Your Thymosin Alpha-1 powder vial
Pro tip
Prepare all supplies on a clean surface before you begin. Having everything ready makes the process smoother and more sterile.
Mixing
Wash your hands thoroughly with soap and water. Gather all supplies on a clean, flat surface.
Remove the plastic cap from the peptide vial and wipe the rubber stopper with an alcohol swab. Let it air dry.
Draw the appropriate amount of bacteriostatic water into a sterile syringe.
Insert the needle into the vial at an angle, aiming at the inside wall of the vial. Slowly push the plunger to let the water trickle down the glass wall -- do NOT squirt directly onto the powder.
Once all water is added, gently swirl the vial in a slow circular motion. Never shake the vial, as this can damage the peptide bonds.
Continue swirling until the powder is completely dissolved and the solution is clear. If particles remain, let the vial sit for a few minutes and swirl again.
Label the vial with the date of reconstitution, the peptide name, and the concentration (e.g. 250mcg per 0.1mL).
Example calculation
For a typical 5mg vial, add 2.5mL of bacteriostatic water. This gives you a concentration of 2mg/mL. Each 0.8mL (80 units on an insulin syringe) equals 1.6mg—one standard dose.
Dose calculation
At 2mg/mL concentration: draw 0.8mL (80 units) for a 1.6mg dose. If using a 3mg vial reconstituted with 1.5mL, you still get 2mg/mL and draw the same 0.8mL.
Pro tip
Always add the bacteriostatic water slowly, letting it run down the side of the vial. Never shake the vial -- swirl gently to avoid damaging the peptide.
Location
Site 01
Abdominal area (2 inches away from navel)
Follow your provider's instructions for this injection site. Rotate sites regularly to prevent tissue damage.
Site 02
Outer Thigh
Middle third of the outer thigh. Keep at least 4 inches above the knee and below the hip. Alternate legs each injection.
Site 03
Upper Arm
Back or outer area of the upper arm. This site may require assistance from another person for proper technique.
Rotate between 3 sites to prevent tissue buildup and ensure consistent absorption.
Pro tip
Rotate your injection sites with each dose to prevent lipohypertrophy (buildup of fatty tissue). Keep a simple log of where you last injected.
Step by step
Wash hands thoroughly with soap and water
Clean the injection site with an alcohol swab and let it dry completely
Pinch about an inch of skin to create a small fold
Insert needle at 45-90 degree angle (45 if lean, 90 if more tissue)
Inject slowly and steadily over several seconds
Release the pinch, wait a moment, then withdraw needle
Apply light pressure if needed—don't rub the area
Pro tip
This peptide uses subcutaneous injection (just under the skin)—this is how it was used in all major clinical trials and provides reliable absorption. Inject at a 45-90 degree angle into pinched skin. Aspirate before injecting to ensure you haven't hit a blood vessel.
Timing
Optimal timing
Best time
Morning or early afternoon injections work well for most people. Some prefer morning to align with natural cortisol rhythms and immune activity peaks.
With food?
Can be taken regardless of food. Thymosin Alpha-1 absorption isn't significantly affected by meals, so fit it into whatever schedule works best for you.
Stacking notes
If using with other peptides like BPC-157, inject at separate sites. Thymosin Alpha-1 works well alongside Thymalin for comprehensive immune support. Space injections at least a few hours apart when stacking.
Sample daily schedule
Morning (8-10 AM) on consistent days
1.6 mg injection
Site: Rotate between abdomen, thigh, and arm
Most protocols use twice-weekly injections on fixed days (e.g., Monday/Thursday or Tuesday/Friday). Consistency helps maintain stable immune support. Rotate injection sites each time to prevent irritation.
Dosing tiers
Preservation
Before mixing
Keep lyophilized powder refrigerated at 36-46°F (2-8°C) for up to 2 years. For longer storage, freeze at -4°F (-20°C). Always store in original vial away from light. Room temperature is acceptable for short shipping periods but refrigerate upon receipt.
After mixing
Refrigerate at 36-46°F (2-8°C) immediately after mixing. Never freeze reconstituted solution—ice crystals can damage the peptide. Keep away from light. Use within 14-21 days for best potency.
Shelf life after mixing
14-21 days
Signs of degradation
Discard the vial immediately if you notice any of these:
Cloudiness or haziness (should be crystal clear)
Visible particles or floaters
Any color change—should remain colorless
Unusual smell—properly stored solution has minimal odor
Important
When to stop
Any signs of allergic reaction—stop immediately and seek medical help
Worsening of any autoimmune symptoms you may have
Persistent fever above 101°F that doesn't resolve
Severe or spreading injection site reactions
Any new symptoms that concern you or feel abnormal
Completion of your prescribed treatment cycle
Thymosin Alpha-1 is approved for specific uses in some countries but remains a research compound for other applications. Always work with a qualified healthcare provider when using any peptide therapy. This information is educational—not medical advice for your specific situation.
Clean technique checklist
Wash hands thoroughly with soap and water before handling supplies
Swab vial tops and injection site with alcohol and let dry
Never touch the needle tip or allow it to contact non-sterile surfaces
Use a new syringe and needle for each injection
Dispose of used sharps in a proper sharps container
Store reconstituted peptides according to the storage instructions above
Published research
Garaci E, Pica F, Matteucci C · 2015
This comprehensive review showed that Thymosin Alpha-1 combined with chemotherapy improved outcomes in melanoma and lung cancer patients. The peptide works on both immune cells and tumor cells, making it uniquely valuable as a cancer adjunct therapy.
Romani L, Moretti S, Fallarino F · 2012
Researchers found that Thymosin Alpha-1 activates multiple immune pathways through Toll-like receptors, enhances dendritic cell function, and importantly activates the IDO enzyme which helps prevent harmful inflammation. This explains how it can both boost immunity AND prevent autoimmune overreaction.
Chen JF, Chen SR, Lei ZY · 2022
This randomized controlled trial of 120 patients showed that Thymosin Alpha-1 improved 90-day survival from 53% to 75% in severe liver failure patients. It also cut infection rates nearly in half and reduced hepatic encephalopathy risk. Major evidence for serious illness applications.
Ancell CD, Phipps J, Young L · 2001
This thorough review documented that Thymosin Alpha-1 cleared hepatitis B virus in 40% of treated patients versus only 9% of controls. For hepatitis C, combination with interferon achieved 65% viral clearance versus 29% with interferon alone. The 2-hour half-life and excellent safety profile were confirmed across all trials.
Clinical Trial NCT04428008 · 2023
This Phase 2 trial in 262 dialysis patients (who are highly vulnerable to infections) evaluated whether Thymosin Alpha-1 could prevent COVID-19 infection. The study completed, showing the continued interest in Thymosin Alpha-1 for vulnerable populations facing infectious threats.
Iino S, Toyota J, Kumada H, et al. · 2004